Thursday, August 28, 2008 - 7:43PM EST

Clinical Trials

1. Pulmonary embolism and deep venous thrombosis in hospitalized adults with chronic obstructive pulmonary disease.

Author
Stein PD; Beemath A; Meyers FA; Olson RE;
Institution
St Joseph Mercy Oakland Hospital, Pontiac 48341-5023, and Wayne State University, Detroit, Michigan, USA. steinp@trinity-health.org
Journal
J Cardiovasc Med (Hagerstown). 2007 Apr;8(4):253-7.
Abstract URL
Click here to view abstract

2. The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression.

Author
Wu HS; Lin LC; Wu SC; Lin JG;
Institution
School of Nursing, National Yang-Ming University, Taipei, Taiwan.
Journal
J Altern Complement Med. 2007 Mar;13(2):253-61.
Abstract URL
Click here to view abstract

3. Effects of a walking aid in COPD patients receiving oxygen therapy.

Author
Crisafulli E; Costi S; De Blasio F; Biscione G; Americi F; Penza S; Eutropio E; Pasqua F; Fabbri LM; Clini EM;
Institution
University of Modena-Reggio Emilia, Department of Pulmonary Rehabilitation, Ospedale Villa Pineta, Italy, Via Gaiato 127, 41026 Pavullo n/F (MO), USA.
Journal
Chest. 2007 Apr;131(4):1068-74.
Abstract URL
Click here to view abstract

4. Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial.

Author
Bourbeau J; Christodoulopoulos P; Maltais F; Yamauchi Y; Olivenstein R; Hamid Q; Bourbeau J; Christodoulopoulos P; Maltais F; Yamauchi Y; Olivenstein R; Hamid Q; Bourbeau J; Christodoulopoulos P; Maltais F; Yamauchi Y; Olivenstein R; Hamid Q;
Institution
Respiratory Epidemiology and Clinical Research Unit, Montreal Chest Institute, McGill University Health Centre, Montreal, Quebec, Canada.
Journal
Thorax. 2007 Nov;62(11):938-43. Epub 2007 Jun 8.
Abstract URL
Click here to view abstract

5. Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology.

Author
Hogg JC; Chu FS; Tan WC; Sin DD; Patel SA; Pare PD; Martinez FJ; Rogers RM; Make BJ; Criner GJ; Cherniack RM; Sharafkhaneh A; Luketich JD; Coxson HO; Elliott WM; Sciurba FC; Hogg JC; Chu FS; Tan WC; Sin DD; Patel SA; Pare PD; Martinez FJ; Rogers RM; Make BJ; Criner GJ; Cherniack RM; Sharafkhaneh A; Luketich JD; Coxson HO; Elliott WM; Sciurba FC; Hogg JC; Chu FS; Tan WC; Sin DD; Patel SA; Pare PD; Martinez FJ; Rogers RM; Make BJ; Criner GJ; Cherniack RM; Sharafkhaneh A; Luketich JD; Coxson HO; Elliott WM; Sciurba FC;
Institution
University of British Columbia iCAPTURE Centre for Cardiovascular and Pulmonary Research, St. Paul's Hospital, Vancouver, BC, Canada. jhogg@mrl.ubc.ca
Journal
Am J Respir Crit Care Med. 2007 Sep 1;176(5):454-9. Epub 2007 Jun 7.
Abstract URL
Click here to view abstract

6. Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.

Author
Petitpretz P; Chone C; Tremolieres F; Petitpretz P; Chone C; Tremolieres F; Petitpretz P; Chone C; Tremolieres F;
Institution
Hopital Andre Mignot, Le Chesnay, France. ppetitpretz@ch-versailles.fr
Journal
Int J Antimicrob Agents. 2007 Jul;30(1):52-9. Epub 2007 May 18.
Abstract URL
Click here to view abstract

7. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema.

Author
Criner GJ; Scharf SM; Falk JA; Gaughan JP; Sternberg AL; Patel NB; Fessler HE; Minai OA; Fishman AP; Criner GJ; Scharf SM; Falk JA; Gaughan JP; Sternberg AL; Patel NB; Fessler HE; Minai OA; Fishman AP; Criner GJ; Scharf SM; Falk JA; Gaughan JP; Sternberg AL; Patel NB; Fessler HE; Minai OA; Fishman AP; Criner GJ; Scharf SM; Falk JA; Gaughan JP; Sternberg AL; Patel NB; Fessler HE; Minai OA; Fishman AP;
Institution
Pulmonary and Critical Care Medicine, Temple University School of Medicine, Philadelphia, PA 19140, USA. crinerg@tuhs.temple.edu
Journal
Am J Respir Crit Care Med. 2007 Aug 1;176(3):253-60. Epub 2007 May 11.
Abstract URL
Click here to view abstract

8. Comparing COPD treatment: nebulizer, metered dose inhaler, and concomitant therapy.

Author
Tashkin DP; Klein GL; Colman SS; Zayed H; Schonfeld WH;
Institution
Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, Calif 90095-1690, USA. dtashkin@mednet.ucla.edu
Journal
Am J Med. 2007 May;120(5):435-41.
Abstract URL
Click here to view abstract

9. A randomized, placebo-controlled trial of bronchodilators for bronchoscopy in patients with COPD.

Author
Stolz D; Pollak V; Chhajed PN; Gysin C; Pflimlin E; Tamm M;
Institution
Department of Pulmonary, Allergy and Critical Care Medicine, University of Massachusetts Memorial Hospital, 55 Lake Ave N, Worcester, MA 01655, USA. stolzd@ummhc.org
Journal
Chest. 2007 Mar;131(3):765-72.
Abstract URL
Click here to view abstract

10. Impact of COPD exacerbations on patient-centered outcomes.

Author
Cote CG; Dordelly LJ; Celli BR;
Institution
Bay Pines Veterans Affairs Health Care System, Respiratory Disease Section 111A, 10,000 Bay Pines Blvd, Bay Pines, FL 33744, USA. Claudia.cote@med.va.gov
Journal
Chest. 2007 Mar;131(3):696-704.
Abstract URL
Click here to view abstract
Pages: 1 2 3